Compare INN & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INN | RGNX |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | 78 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 515.7M | 418.1M |
| IPO Year | N/A | 2015 |
| Metric | INN | RGNX |
|---|---|---|
| Price | $5.11 | $9.35 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $4.50 | ★ $28.75 |
| AVG Volume (30 Days) | ★ 774.7K | 501.6K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.41% | N/A |
| EPS Growth | N/A | ★ 18.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $10,393,000.00 |
| Revenue This Year | $2.00 | $51.21 |
| Revenue Next Year | $1.96 | $19.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 126.48 |
| 52 Week Low | $3.98 | $6.89 |
| 52 Week High | $6.00 | $16.19 |
| Indicator | INN | RGNX |
|---|---|---|
| Relative Strength Index (RSI) | 63.57 | 56.09 |
| Support Level | $4.85 | $7.68 |
| Resistance Level | $5.52 | $9.41 |
| Average True Range (ATR) | 0.19 | 0.47 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 68.97 | 78.95 |
Summit Hotel Properties Inc is a U.S.-based hotel investment company focusing on select-service hotels in the upscale and upper-midscale properties in the U.S. Substantially all of Summit's assets are held and operated by its Operating Partnership, Summit Hotel OP, LP, in which the company holds general and limited partnership interests. The firm has one segment in activities related to investing in real estate. Summit's revenue streams include Room and Other hotel operations revenue. Room comprises the majority of total revenues. The company's hotels are located in various markets, such as corporate offices, retail centers, airports, state capitols, convention centers, and leisure attractions. Summit's hotels operate under brands, including Marriott, Hilton, Hyatt, and Holiday Inn.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.